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ABSTRACT 
 
Yi Yuan: The Role of Thiocyanate in Defense of Airway Surfaces against Pseudomonas 
aeruginosa: Dysfunction in Cystic Fibrosis 
 (Under the direction of Roland.R.Arnold) 
Objectives: To understand the role of thiocyanate (SCN-) in CF airway infection, we will 
determine potential antimicrobial mechanisms of SCN- on P. aeruginosa and the influence of 
SCN- on hypochlorite (HClO) -killing (a major microbicidal mechanism of inflammatory cells) 
on P. aeruginosa; and compare the effects of these antimicrobial reagents on mucoid and non-
mucoid strains of P. aeruginosa. 
Materials and Methods: The conventional strain PAO1 and its mucoidy mutant (PAM) 
and a mucoidy clinical isolate (C3873) of P. aeruginosa were included. Target bacteria were 
exposed to different treatments including H2O2, LPO/H2O2 and HClO with and without SCN
-. 
Three distinct techniques were employed to examine the antimicrobial effects of these treatments 
including influence on planktonic growth, recovery of colony forming units and inhibition of 
growth on an agar surface.  
Results: SCN with LPO is able to enhance the inhibitory effect of H2O2 on P. aeruginosa, 
due to conversion to the antimicrobial species OSCN. SCN can also rescue the P. aeruginosa 
from HClO-killing at optimal concentrations. The mucoidy character did not afford protection to 
P. aeruginosa from inhibition by H2O2, HClO or LPO/SCN/H2O2 system under either planktonic 
or biofilm condition.  
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Conclusion: SCN might play a role in airway defense by preventing P. aeruginosa 
infection. Diminshed amounts of SCN- resulting from CFTR mutation may contribute to CF lung 
damage
 iii 
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CHAPTER 1: A Review of the Literature 
Introduction of Cystic fibrosis and Cysitic fibrosis lung infection 
 
Cystic fibrosis (CF) is an autosomal recessive genetic disorder that affects 1 in every 
2,500 individuals of Caucasian origin, making it one of the most common lethal genetic diseases 
aﬀecting the Caucasian population in the United States.(1)  
This disease is caused by mutations of the gene that encodes the CF transmembrane 
conductance regulator (CFTR)(2)., CFTR is a multidomain integral apical membrane 
glycoprotein member of the ATP-binding cassette (ABC) that is required to control ion and fluid 
homeostasis on epithelial surfaces.  Dysfunctions in the CFTR epithelial anion channel are 
fundamental to the etiology of CF, a disease in which all individuals clinically diagnosed have 
mutations in both CFTR alleles.  The absence of this precisely regulated anion channel activity 
disrupts ionic and water homeostasis on exocrine epithelial surfaces resulting in dehydrated 
accumulations of macromolecules. CFTR is widely expressed by a variety of epithelial cells and 
thus multiple organs could be effected by mutations of CFTR, including sweat duct, airway, 
pancreatic duct and intestine. Different symptoms and signs could be observed from CF patients, 
such as salty-tasting skin, exocrine pancreatic disease, CF-related diabetes and CF lung infection. 
Among all the symptoms, lung infection is currently the primary cause of morbidity and 
mortality in CF. (1) 
In normally healthy airway, there are a variety of innate host defense mechanisms 
operating to maintain the airway in aseptic conditions, where the pathogens inhaled from the 
 2 
 
environment can be effectively cleared.  However, dysfunction of CFTR could result in airway 
immune defense defective, such that the patients with CF experience chronic airway infection 
with severe, improper inflammatory response, which eventually leads to airway obstruction, 
tissue destruction and failure of respiration. (3) 
One of the major reasons for CF lung infections, defined as an inappropriate immune 
response, is that a large number of neutrophils are recruited into airway.(4) Notably, neutrophils 
are not the normal immune cells participating in airway host defense system. These cells release 
granules with numerous proteases, enzymes, and reactive oxygen species, including hydrogen 
peroxide (H2O2) and hypochlorite (HClO) which could defeat the pathogens in airway.  
Meanwhile, these released chemicals could also cause unrecoverable deterioration of lung 
function.(5) For example, a large number of proteases could increase mucus viscosity thereby 
leading to airway obstruction; the ROS result in airway epithelia injuries thereby exacerbating 
pulmonary deterioration for CF patients. Therefore, controlling of lung inflammation is 
considered as a promising therapeutic target in CF area.(6)  
On the other hand, the unique pathogens profile in CF lung infection has drawn a lot of 
attention in CF research. While most of immune compromise diseases predispose to infections 
with a variety of pathogens, very limited species of pathogens can be identified in CF lung 
infections, including Staphylococcus aureus, Haemophilus influenza, P. aeruginosa and 
Stenotrophomonas maltophilia.(1) Notably, the pathogens in the CF lung are usually acquired in 
an age-dependent tendency. S. aureus and H. influenza are the most common organisms at the 
early stage of CF lung infection. Along with the progress of CF lung disease, P. aeruginosa 
becomes the prominent pathogen, infecting approximately 80% of the CF patients and its 
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conversion to a mucoidy phenotype is ultimately the primary cause of morbidity and mortality in 
CF. (7) 
All the evidences shared in previous paragraphs suggest that a CF airway is capable of 
forming a very unique environment such that specific pathogens are selected to adapt to such an 
environment. As CFTR serves as ion channels onto epithelial cells, it has been hypothesized that 
the CFTR mutations cause defects in the concentrations of select ions on airway epithelial cells, 
and thereby lead to dehydrated airway surface layer and thickened mucus in CF lung. (8)These 
changes could significantly weaken the ciliary clearance of pathogens in the airways, which is an 
important physical barrier for maintaining the airway sterility. The failure of ciliary clearance 
directly leads to lung infection in CF patients.(9) However, this abnormal physiology fails to 
provide an explanation as to why P. aeruginosa is the predominant pathogen in CF as ciliary 
clearance would not be pathogen specific. This means other pathogens should also take 
advantage of this defective host defense. Therefore, further studies concerning the link between 
CFTR mutation and the predisposition of the CF lung to P. aeruginosa infection is still needed.  
Defective ions transport in CF airway  
Although CFTR was originally identified as a chloride channel, growing evidence 
suggest that CFTR is capable of directly or indirectly regulating the transportation of other 
anions, including bicarbonate (HCO3
-), reduced glutathione (GSH) and thiocyanate (SCN-). It 
has been reported that various exocrine secretions of the CF patients are deficient in GSH, HCO3
-, 
SCN- and NO, which play a role in host immune system. For example, HCO3
-has been shown to 
be a critical determinant of the nature of iron binding by lactoferrin, (6) a potent antimicrobial 
protein of exocrine secretions and the polymorphonuclear neutrophilic leukocyte, and determines 
the iron scavenging (host protective) vs. bactericidal activities of LF.(10) GSH is utilized by 
 4 
 
epithelial cells to control oxidative damage from inflammatory response, due to its potential 
antioxidant role that can consume reactive oxygen species from inflammatory reaction.(11) 
Studies showed that decreasing GSH leads to increased oxidative stress, and further alters the IL-
8 gene expressions and leads to defects in bacteria killing in airway.(12) SCN- is another 
purported antioxidant in human body that participates in diminishing of oxidative stress from 
inflammation.(13) More importantly, it can serve with H2O2 as the substrate of peroxidases, 
including lactoperoxidase (LPO) and myeloperoxidase (MPO) to generate the antimicrobial 
molecule hypothiocyanite (OSCN-). (14) It also reacts non-enzymatically to convert OCl- to 
OSCN-  serving the dual purpose of host protection and more specific antimicrobial activity. 
Therefore, the overall hypothesis of our studies is that CFTR mutation interrupts the 
critical balance of ionic composition on the airway surface.  This disruption of ionic 
homeostasis in the CF airway results in a unique environment that can be utilized by P. 
aeruginosa to colonize and thrive. The overall purpose of our studies is to delineate the 
potential roles and mechanisms of action of these ions in airway innate immunity, and reveal the 
relationship between defective of ions and the selective susceptibility of the CF lung to P. 
aeruginosa infection.  
Introduction of Thiocyanate and its role in immune system 
Thiocyanate (SCN-) is a strongly acidic pseudohalide thiolate that can reach millimolar 
concentrations in biological fluids, include saliva, milk, airway epithelial lining fluid (ELF) and 
nasal lining fluid. The original sources of SCN- in the body are from diet, but it is unclear 
whether SCN can be synthesized from an endogenous source of cyanide. (15)  
The vast majority of SCN in the human body concentrates in the secretions of exocrine glands 
that bathe mucosal surfaces. For example, saliva contains the highest concentration (500 – 
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3000M) of SCN; nasal airway fluid has been reported to range from 100-1200M SCN. The 
samples from airway epithelial lining fluid are reported to range from 30M to 650M.  (15) 
Plasma values of SCN range between 5 and 50M, and this range is as low as 0.1-4M in milk. 
It has been suggested that the higher concentrations of SCN in saliva result in more potent 
antimicrobial defenses required as the oral cavity is exposed directly to a hostile environment (16) 
In 1962, an anti-bacterial agent was reported in saliva with activity against Lactobacillus casei 
(17) that was dependent on SCN. This report described that SCN can be oxidized by H2O2, a 
reaction catalyzed by the peroxidase enzyme in human body, and was responsible for 
antimicrobial activities in saliva. The product was later identified as hypothiocyanite (OSCN-). 
Since then, the antibacterial properties of the peroxidase/SCN/H2O2 have been identified in ELF, 
NLF, milk, and tears, and are presumed to play an important role in host immune defense at 
mucosal surfaces.(15) 
The mechanism for HOSCN inhibition of bacteria is due to its capability of selective 
reaction with sulfhydryl groups, resulting in the oxidation of proteins to sulfenylthiocyanates 
(RS-SCN). When bacteria are exposed to HOSCN, the enzymes containing essential thiol groups 
can be inactivated due to oxidation by OSCN-. Since enzymes are critical for glycolysis 
metabolism in microbes, the growth of bacteria will be interrupted due to inactive metabolism 
when exposed to OSCN. (18) On the other hand, it has been reported that after treatment with 
OSCN, the growth of bacteria can be recovered by removing residual OSCN through washing 
procedures and the restoration of the essential sulfhydryls with reducing agents such as 
mercaptoethanol and dithiothreitol, which suggested that the inhibitory effects of OSCN are not 
bactericidal, and the inhibitory effect is reversible. (19) 
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Most of the early research on the SCN dependent peroxidase system focused on saliva 
and the regulation of the metabolism of the cariogenic bacteria that colonize the tooth surface. 
(20) Studies indicated that the concentrations of SCN and LPO in saliva were such that H2O2 
levels were rate limiting and that the bacteria in the oral cavity produced sufficient incidental 
H2O2 during their metabolism to engage the LPO system.(21) In addition, reports showed that 
the combination of LPO/SCN/H2O2 has the capability of inhibiting oral yeast such as Candia 
albicans (22) and virus, e.g. Herpes simplex virus.(23) When the importance of LPO in airway 
bacterial clearance was first reported by Gerson et al. in 1999, the potential contributions of SCN 
in the defense of airway surfaces gained attention. Gerson et al. identified the LPO/SCN/H2O2 
system in sheep airways that inhibited bacteria, and inhibition resulting from LPO could 
significantly impair bacterial clearance in the airways. (24) Subsequently, CFTR was reported to 
be responsible for transportation of SCN, and the consequent decrease in SCN concentrations in 
the CF airway could lead to poor bacterial clearance and eventually CF lung infections. (25) 
These observations suggested that SCN could be a potential therapeutic agent for 
treatment of CF lung infection. However, the mechanism of inhibitory effect of LPO/SCN/H2O2 
system on CF pathogens is still lacking. In contrast to the studies with oral pathogens, more 
questions remain regarding the mechanisms of the antimicrobial actions of the LPO/SCN/H2O2 
system on potential airway pathogens. For example, most of the studies have only exposed 
bacteria with LPO/SCN/H2O2 treatment in the non-growth conditions of nutrient poor buffers.(13) 
In contrast, our studies focused on defining the antimicrobial effects under bacterial growth 
conditions. Another important question was whether the antibacterial effect of LPO/SCN/H2O2 
system could be influenced by other molecules present in the environment of airways. As 
discussed in previous sections, different ions can be identified in airway surface that might 
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cooperate with or antagonize potential host defense factors, such that maintanence of a healthy 
airway may depend on the balance of different ionic components instead of one single 
component. 
Besides the antibacterial role of SCN, the antioxidant properties of SCN might also play 
important roles in the maintenance of a healthy airway environment. The antioxidant properties 
allow SCN reaction with ROS and reactive nitrogen species (RNS) resulting from the 
inflammatory response in airways. SCN would also compete with chloride for peroxidase 
catalyzed reaction with H2O2, redirecting from the more host destructive HOCl to the more 
microbe specific HOSCN. Such reactions are capable of dampening oxidative stress in the lungs 
and thereby reducing the damage to lung epithelial cells.  Although the mechanistic connection 
of abnormal CFTR function to lung infection has not been fully elucidated, the severe 
progressive inflammation aroused by lung infection directly leads to the failure of airway 
functions for CF patients, One important tissue damaging factor identified in lung inflammation 
in CF patients is the ROS generated by neutrophils in the CF airway.(3) It has been proposed that 
SCN could limit the accumulation of tissue-damaging ROS such as H2O2 and hypochorite (OCl
-) 
in several ways. (14) First, SCN can rapidly react with HClO to generate OSCN- and Cl- in a 
non-catalytic reaction. Second, SCN can compete with Cl- for the myeloperoxidase (MPO) 
catalyzed oxidation by H2O2 produced by neutrophils, and thus reduce the production of 
cytotoxic molecules, e.g. HClO in favor of the more microbe specific, OSCN-. (26) Third, 
lactoperoxidase (LPO) in the airway catalyzes the oxidation of SCN to OSCN, but in contrast to 
myeloperoxidase is enzymatically unable to use Cl-. Thus this SCN dependent enzyme system 
consumes H2O2 limiting its availability for generating more host destructive species. (24) Based 
on these mechanisms, SCN has been proposed as a promising reagent to protect host cell from 
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inflammatory damage in CF lung infections. However, the potentially protective impact of the 
antioxidant role of SCN on the CF lung pathogen, P. aeruginosa has never been systematically 
studied. Since antibacterial functions serve as the primary function of ROS in the inflammatory 
response, it is important to understand both the positive and negative impacts of antioxidant 
properties of SCN. Therefore, we studied whether P.aeruginosa can be protected from the 
bactericidal activities of the ROS HClO or H2O2 by adding SCN or perhaps redirected to the 
more bacteria specific OSCN.  
In the present study, we examined the effects of SCN towards P. aeruginosa. The effects 
included growth inhibition from the LPO/SCN/H2O2 system, as well as the antioxidant role of 
SCN that influences bacterial killing activity of HClO. Through this part of the study, we 
establish a better understanding of the role of SCN serving as an important part in the host 
defense in the normally health airway, and how the defective SCN transport associated with 
CFTR mutation is related to the selective increase in susceptibility to P. aeruginosa infection in 
the CF airway.  
The adaption of P. aeruginosa in CF lung infection 
Pursuant to establishing the link between defective CFTR function and chronic 
P.aeruginosa infection in the CF airway, it is important not only to understand potential defects 
in innate immunity, but it is also important to understand the characteristics and particularities of 
the CF lung pathogens.  
Although multiple microbial species are able to colonize in the CF airway, it has been 
widely accepted that the infection of P. aeruginosa is one of the most clinically important CF 
pathogens accounting for the vast majority of morbidity and mortality associated with this 
disease. The prevalence in the CF respiratory tract cultures of P. aeruginosa is in the range of 
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10%-30% by the age of five years, but the incidence rate sharply increases to 80% after the age 
of 18. Early acquisition of this pathogens is an indicator for worse prognosis. Detection of P. 
aeruginosa is highly associated with the rate of deterioration of lung function for CF patients. 
(27) 
An important characteristic of P. aeruginosa that likely contributes to its successful 
colonization in CF lung is high degree genetic flexibility, which allows active adaptation to 
evolving environments especially with the pressures imposed by the various elements of the 
mucosal immune system.  Studies have shown that even single clones of P. aeruginosa initially 
isolated from a CF lung could develop clones with numerous different gene expression profiles, 
suggesting that this pathogen could undergo a series of genetic mutations along with the 
progression of the disease.(7) This characteristic of P. aeruginosa suggests that there are 
selective pressures for optimization of the clonal types that contribute to the disease process that 
defines characteristic CF-associated pathology. Colonies evade immune clearance and adapt to 
the environment of high inflammatory stress and eventually thrive in the CF lung. 
At the early stage of infection, P. aeruginosa isolates from CF lung present a phenotype 
that is non-mucoid, smooth (complete outer membrane lipopolysaccharide (LPS)), motile and 
relatively susceptible to antibiotics.  Such phenotypes indicate that this pathogen is acquired 
from the environment. However, the strains isolated from chronically infected CF patients have 
alterations in numerous virulence factors. For example, the chronic P. aeruginosa CF isolates 
show a rough colony phenotype, which is caused by the loss of the O-side chain of LPS that is 
generally associated with an increase in permeability of the outer membrane and an increased 
susceptibility to hydrophobic molecules. (28) CF chronic P. aeruginosa also have lost the ability 
to express flagella and consequently are non-motile. The gene lasR that plays an important role 
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in the quorum sensing system is also inactive due to mutation in chronic P. aeruginosa. (29)  In 
addition to these alterations in potential virulence factors, the metabolism of P. aeruginosa also 
undergoes a series of alterations in order to acquire nutrients for high-density growth in the CF 
lung. Studies have shown that P. aeruginosa prefers to catabolize amino acids over other carbon 
sources like lactate and glucose. Moreover, under the hypoxic and anaerobic conditions 
presumably created by chronic oxygen consumption from the excessive inflammation in the 
airway and possibly by limited oxygen diffusion through the alginate extracellular matrices of 
mucoidy phenotypes, P. aeruginosa is able to utilize NO3/NO2 as alternative electron acceptors 
to oxygen for respiration or can use limited fermentation of arginine as an energy source. (30) 
 
The conversion to mucoidy phenotype of P. aeruginosa in CF lung infection;  
Among all those adaptions, it is generally accepted that the adaptation to the mucoidy 
phenotype is the most uniquely characteristic and significant virulence determinant of chronic 
CF airway disease.(31) Mucoidy is the result of overproduction of the anionic exopolysaccharide 
alginate, a polymer of D-mannuronic and L-guluronic acid. Studies found that the expression of 
genes accounting for the over expression of alginate, such as MucA , MucB and MucC, has been 
upregulated in mucoid strains.  It is believed that there is a spontaneous selection of these 
mutants during the process of CF lung disease, and thereby the vast majority of P. aeruginosa 
isolates from late stage of CF lung infection characteristically are of the mucoidy phenotype. 
After switching to the mucoidy phenotype, P. aeruginosa is considered to be impossible to clear 
by the immune system. (32) Thus, detection of mucoidy P. aeruginosa is considered to be 
associated with poor prognosis and increased lung tissue damage. In the clinic, the conversion to 
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mucoidy becomes a well-established indicator of failed innate immunity and chronic infection in 
CF lung. 
It is believed that the hyperproduction of alginate promotes the persistence of 
P.aeruginosa in the CF lung, for its function as protection on the surface of P. aeruginosa 
against the environmental stresses in the CF lung. The studies indeed have shown that, when 
non-mucoid strains are treated with low levels of H2O2 or exposed to active PMNs in vitro, the 
formation of mucoid variants can be observed.(29) In addition, another study applied a mouse 
lung-infection model to show that anaerobiosis and lung infection can rapidly induce alginate 
production from non-mucoid P. aeruginosa. (33)However, whether the mucoid phenotype 
protects P.aeruginosa from ROS in the inflammatory environment still lacks clear evidence.  
In our study, we were therefore also interested in the how the LPO/SCN/H2O2 system influences 
the mucoid P.aeruginosa. First of all, it is unknown whether alginate production could protect a 
mucoid strain from the inhibitory effects of OSCN. Second, since antimicrobial function of 
OSCN was speculated to target the metabolism of glycolysis the production of alginate requires 
the synthesis of the alginate precursor guanosine diphosphate (GDP)-mannuronic acid. (18) Thus, 
we need to address the question concerning whether LPO/SCN/H2O2 system could suppress the 
formation of mucoidy in P. aeruginosa, and thereby can be applied to control the late stage of 
the chronic CF lung infection.  
Therefore, we will investigate the effects of ROS on the mucoid strains of P.aeruginosa 
and compare the results with the non-mucoid P.aeruginosa. Two mucoid strains were selected in 
this study. One is a laboratory derived mucoid mutation of PAO1. The other one is a clinical 
isolate from the sputum of a CF patient.  
Statements of purpose, hypothesis and specific Aims: 
 12 
 
 
 This project focused on the role of one of the ions purported to be regulated by CFTR, 
thiocyanate (SCN) and reported to be deficient in the CF airway. This molecule has been 
suggested to contribute airway immune defense by reacting with H2O2 under catalysis by LPO to 
generate antimicrobial species. Moreover, it is an important antioxidant in airway that can limit 
oxidative stress in the airway from inflammatory response. As the SCN transportion is down-
regulated by dysfunction of CFTR, it was an aim of these studies to understand whether the 
reduction of SCN in CF airway surface liquid could play a role in susceptibility to P. aeruginosa 
infection that finally leads to the destruction of the airway apparatus.  
Three specific aims were developed to test the hypothesis that SCN plays an important role in 
preventing P. aeruginosa from establishing infection in normally healthy airway.  
• Aim 1: to determine potential antimicrobial mechanisms of SCN on P. aeruginosa   
If SCN contributes to the resistance of the healthy airway to P. aeruginosa infection, the 
potential antimicrobial role of SCN may be important in the early stage of CF airway infection. 
We will study the influence of SCN on the antimicrobial effects of H2O2 on P. aeruginosa. 
Moreover, spiral plating assay will be applied to understand the mechanisms of antimicrobial 
effects of the LPO/SCN/H2O2 system. Lastly we will study the influence of GSH, another 
important antioxidant co-exists with SCN in the healthy airway, on LPO/SCN/H2O2 system.  
• Aim2: To determine the influence of SCN on hypochlorite-killing of P. aeruginosa.   
After the initial infection of P. aeruginosa in CF airway, large numbers of neutrophils are 
recuited and release ROS against pathogens, which also directly cause host cell damage. To 
understand the influence of SCN on HClO, a ROS species from neutrophils is also provide more 
information about the role of SCN in inflammatory stage of CF lung infection. In this 
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experiment, P. aeruginosa were exposed to vaious concentration of HClO, and various 
concentrations of SCN were added to determine the influence of SCN on HClO-killing.  
• Aim3: To compare the effect of antimicrobial reagents on mucoid vs. non-mucoid 
strains of P. aeruginosa   
P. aeruginosa generates large quantities of alginate to switch to mucoidy phenotype through the 
progression of CF lung infection. It is proposed that the conversion to mucoidy of P. aeruginosa 
results in protection of P. aeruginosa from the host immune elements. Comparison of the 
differential susceptibilities of mucoidy and non-mucoidy strains to ROS and LPO/SCN/H2O2 
system is important to gain insight into the role of SCN in the late stage of the CF lung 
infection. Two mucoidy strains of P. aeruginosa - one from mutation of PAO1, the other a CF 
patient isolate – will be compared with a laboratory standard smooth, non-mucoid strain. All 
strains will be tested for relative susceptibilities to H2O2, HClO, and LPO/SCN/H2O2 system.  
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CHAPTER 2: The Role of Thiocyanate in Defense of Airway Surfaces against 
Pseudomonas aeruginosa: Dysfunction in Cystic Fibrosis 
Materials and Methods 
 
Bacterial and reagents 
 
PAO1: ATCC BAA47 was acquired from the American Type Culture Collection, 
Rockville, MD., SCN was purchased from Mallinckrodt Chemical Works (St. Louis. MO), LPO, 
GSH and Catalase were purchased from Sigma (St. Louis. MO), H2O2 was purchased from 
Mallinckrodt Baker. (Phillipsburg. NJ), HClO was purchased from Clorox (Oakland, CA). TSB 
and TSA were purchased from Becton Dickinson (Sparks, MD) 
Microbial growth and storage. 
Trypticase soy broth (TSB) media (3.7mL) were inoculated with the test pseudomonas 
strains and cultured overnight at 37oC. The following day, the cultures were streaked onto 
trypticase soy agar (TSA) plates for colony isolation. New cultures were inoculated from single 
colonies and grown overnight at 37oC. Aliquots of pure cultures were preserved by freezing a 
mixture of 0.1ml of bacterial culture and 0.5ml of skim milk at –80oC.  
Growth curves of bacterial cultures were inoculated with ten-fold dilutions.  
Bacterial cultures from isolation plates were grown overnight in TSB at 37oC. On the day 
of experiments, the cultures were diluted to a MacFarland standard 0.5 (~ 108 CFU/mL). An 
aliquot of 0.1ml of the diluted bacterial culture was further diluted into 0.9ml volumes of TSB to 
affect a serial 10-fold dilution. 
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Replicate aliquots of 20l of each dilution of the bacterial suspension were added to sterile 96 
well microtiter wells as a starting inoculum, 180l of TSB were added to each well. The 
microtiter plate was placed in the kinetic spectrophotometer. The temperature of the chamber 
inside the spectrophotometer was set constant at 37°C. Each test lasted for 24 hours, and the 
machine automatically measured the optical density at 610nm every 30 min after shaking for 15 
sec.  The growth curves were captured by the curve fitting software Microsoft  and the time 
required to reach an OD value of 0.2 was determined for each growth as the lag time to onset of 
exponential growth.  
Antimicrobial effects of H2O2 and LPO/SCN/H2O2 system 
For H2O2 and HClO killing, microbes were suspended to 10
6 CFU/mL in TSB media. 
Killing reactions were carried out in duplicate wells of 96-well microtiter plates containing 
various concentrations of H2O2 or HClO in a volume of 200l of TSB. Then 20l aliquots of 
density adjusted bacterial suspension were added to each well of the microtiter plate. The 
microtiter plates and placed in spectrophotometer (SpectraMax2, Molecular Devices). The 
temperature of the chamber inside the spectrophotometer was maintained at 37°C. The level of 
inhibitory effect of each treatment is determined by onset time to exponential growth of the 
growth curves for each sample.  The onset time is correlated with number of recoverable colony 
forming units for each condition.  
For measuring antimicrobial effect of the LPO/SCN/H2O2 system, LPO powder (Sigma, 
St. Louis. MO) was diluted into sterile 150mM saline to prepare the working solution (10U/ml), 
and 10l of this LPO solution were added to the appropriate wells of the 96-well microtiter 
plates, followed by 20l of bacterial suspension. SCN was diluted into TSB media to 2mM, and 
various concentrations of H2O2 were achieved by dilution into TSB media containing 2mM SCN. 
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Aliquots of 200l of H2O2 dilutions with 2mM SCN were then added to each test well of the 
microtiter plates. The inhibitory effects were determined as delays in onset time to exponential 
growth for each test sample and control. 
Spiral plating of microbe and measurement of colonies 
Target bacteria were adjusted using MacFarland standard to achieve a suspension of ~105 
CFU/mL in TSB media. H2O2 was serially diluted in TSB containing 2mM SCN. In the group of 
LPO/SCN/H2O2 treatment, 200l of LPO working solution was added into tubes first, followed 
by the bacteria suspension.  2ml volumes of the serial dilutions of H2O2 were added into the 
mixture last. In the group of H2O2 treatment only, 2ml volumes of H2O2 dilutions were added to 
200l bacterial suspensions. 200l bacterial suspensions were mixed with 2ml volumes of TSB 
as negative controls. All the mixtures were incubated at 37oC in ambient atmosphere. After 0, 2, 
4, and 6 hours, 49.2l of the mixture was spirally plated onto TSA plates using spiral plater 
(Spiral Systems Model DU, Microbiology International). All plates were incubated at 37oC 
overnight either in an ambient atmosphere or in 5% CO2, after which the total colony forming 
units (CFU)/ml were counted using an automated colony counter, Protocol 3 (Microbiology 
International), with software designed for the purpose. 
Disk diffusion assay of effect of bacteria growth.  
Volumes of 100l of the test bacteria suspension containing 108 CFU/ml of bacteria cells 
were spread confluently on the surface of TSA plates of each strain by sterile cotton swaps. 
Blank antibiotic sensitivity paper discs (6 mm in diameter) were evenly spaced on the inoculated 
surface of the plates and titrated concentrations of the test reagents (7ul) were added aseptically 
with a micropipette to each disc. The prepared plates were incubated either in an ambient 
atmosphere or in 5% CO2 at 37°C for overnight. The diameters of any zones of growth inhibition 
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resulting in the bacterial lawn were measured in millimeters (including disc diameter 6 mm). The 
experiments were performed in triplicate. 
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Results 
Measurements of bacteria density by growth curve: 
In order to determine the antimicrobial effects of the various agents on actively growing 
P. aeruginosa, we developed a method to determine the influence of a reduction in colony 
forming units on bacterial growth in broth cultures. The principle of the method is shown in Fig. 
1. In order to establish a standard curve, the starting bacterial density was adjusted to 108 
CFU/mL using comparison to MacFarland standards and serial ten-fold dilutions of this bacterial 
suspension was used to inoculate replicate wells of a 96-well microtiter plate. The growth curve 
kinetics at 37°C was monitored by measuring the change in the optical density at 610nm 
automatically every 30 minutes after 15 seconds of shaking. As shown in Fig. 1(b), titration of 
the bacterial inoculum number resulted in a prolongation in the lag phase, but did not influence 
the generation time, the length of time in exponential growth or the maximum bacterial density 
achieved. With a theoretical inoculum size of 100 CFU/ml, the bacteria were able to reach 
stationary phase within 24h. The lag phase ends with transition to exponential growth. The size 
of the starting inoculum was directly proportional to the time it takes to enter log phase growth 
and this time to exponential growth can be uniformly captured by determining onset time to an 
OD610nm of 0.2 (Fig. 1(b)). Linear regression was performed between the starting inoculum size 
(CFU/ml) and the time to achieve this threshold OD value, i.e. the onset time. As shown in Fig. 
1(c), the correlation is highly linear with a correlation coefficient of 0.9943.  
The high linearity and correlation shown in Fig. 1(c) permitted the establishment of 
standard curves for each of the target bacteria to allow estimates of residual CFU/ml resulting 
from the experimental treatment protocols.  
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SCN did not influence growth of bacteria by itself: 
 In order to study the growth of PAO1 under the influence of LPO/SCN/H2O2 system, we 
needed to first investigate if SCN alone has any effect on the growth character of P. aeruginosa. 
A titration of concentrations (0.75 - 40mM) of SCN was added to replicate wells of the culture 
media prior to inoculation with PAO1.  As shown in Fig. 2, after overnight growth, there were no 
discernible differences in the growth kinetics or onset times with concentrations of SCN to 
40mM. The data from this set of experiment indicate that SCN alone does not influence P. 
aeruginosa growth.  
Inhibitory effect of H2O2 on PAO1 is influence by bacteria density.   
As H2O2 is the defining substrate of the peroxidase system, in order to understand effect 
of LPO/SCN/H2O2 system on growth of bacteria, we investigated the influence of H2O2 alone 
on PAO1 growth. A titration of concentrations (0. 10mM to 110mM) of H2O2 was tested against 
a starting inoculum of 107 CFU/ml of PAO1. The data (fig. 3A) indicated that the presence of 
H2O2 in the culture media resulted in a dose dependent delay in onset time and a standard curve 
estimated reduction in CFU of 100 fold with a concentration of H2O2 of 64mM. When the initial 
target density of PAO1 was reduced to 105 CFU/ml as a starting inoculum, there was total 
inhibition with H2O2 concentrations as low as 1.7 mM. P. aeruginosa produces the hydrogen 
peroxide-specific enzyme catalase that should afford a level of protection against exogenous 
H2O2. In order for H2O2 to inhibit P. aeruginosa, the concentration of the H2O2 must exceed the 
enzymatic activity of the the bacterial catalase. As the target density is increased, the activity of 
the bacterial catalase would increase reflecting an increased resistance as the population 
increases. This would suggest that P. aeruginosa would be relatively more resistant to H2O2 
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when compared to the susceptibility of a species (S. mutans) that does not make catalase. 
Furthermore there should not be the same effect on susceptibility by increasing target density if a 
ROS agent that is not a substrate of catalase (HClO) is tested for antimicrobial activity.  To prove 
this assumption, the same two densities of P. aeruginosa were treated with HClO. No influence 
from bacteria density on HClO inhibition was observed. (Fig. 3b) As further evidence that the 
target density influence on susceptibility to H2O2 of P. aeruginosa is due to catalase, the 
bacterial density of S. mutans did not have demonstrable influence on susceptibilities to 
treatments with either H2O2 or HClO. (Figure 4c, d).  
The enhanced antimicrobial activity of H2O2 is dependent on both LPO and SCN. 
With the understanding of effect of H2O2 and SCN alone on PAO1 growth, we also tested 
how LPO/SCN/H2O2 system influences PAO1.  First, with titrated concentrations of H2O2 in the 
culture media of PAO1, complete inhibition can be observed when 32mM or greater H2O2 was 
added. The addition of either SCN (2mM) or LPO (10U/ml) to H2O2 concentrations less than 
32mM resulted in no additional antimicrobial activity.  However, when LPO was added to the 
combination of SCN and H2O2 (6.88mM), growth was completely inhibited. This observation 
provides evidence that LPO/SCN/H2O2 system presents an inhibitory effect on PAO1 growth and 
can amplify the antimicrobial activity of H2O2 alone. 
Dose dependence of H2O2 /LPO for growth inhibition of PAO1: 
 The key point of this study is to determine whether the product resulting from the 
LPO/SCN/H2O2 system is more effective than H2O2 alone. We thereby investigated whether this 
inhibitory effect of LPO/SCN/H2O2 system is dose-dependent on LPO concentration. In this 
experiment, gradient concentrations of LPO (from 10 to 0.3125U/ml) and H2O2 (from 6.88 to 
0.78mM) were added to TSB plus 2mM SCN and 106 CFU/mL of PAO1. As shown in Figure 5, 
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the level of inhibition was dependent on both the activity of the LPO and the concentration of 
H2O2. This observation was consistent with the generation of a new antimicrobial species, most 
likely OSCN, to which PAO1 was more susceptible.  
The influence of bacteria density on antimicrobial effect of LPO/SCN/H2O2: 
 It is known that due to the catalase on the cell surface of P. aeruginosa, the inhibitory 
effect of H2O2 can be weaker in higher density of bacteria. To further investigate the effect of 
LPO/SCN/H2O2 system, we design the experiment to measure whether the inhibitory effect of 
OSCN can also be influence by density of P. aeruginosa. 
  As showed in Figure7A, two inoculum densities of PAO1 (107 CFU/mL and 106 CFU/mL) 
were treated in the presence of 2mM SCN in microtiter format with H2O2 in two-fold dilutions 
added vertically, and the LPO in two-fold dilutions added laterally as a checkerboard. In the 
samples with lower density of P. aeruginosa, only H2O2 in 6.88mM and 3.44mM concentrations 
totally inhibited growth of bacteria. In the rest of the groups, we can observe that inhibitory 
tendency corresponded with concentration of LPO and H2O2, which indicated that the level of 
inhibition of P. aeruginosa is based on the concentration of OSCN generated from enzymatic 
oxidation of SCN by H2O2.  
With both 1.72 mM H2O2 and 0.86mM H2O2, the same inhibitory activity can be 
achieved with either of the two target densities of P. aeruginosa. (Fig 7C) Therefore, unlike with 
H2O2 in the absence of LPO, target density did not influence the inhibitory effect of 
LPO/SCN/H2O2 system.  
Effects of treatment with the LPO/SCN/H2O2 system on P. aeruginosa on recoverable 
CFU/ml and colony morphology. 
 22 
 
The data reported in the previous sections proved antimicrobial effect of LPO/SCN/H2O2 
system on the CF lung pathogen, i.e. P. aeruginosa. This inhibition was interpreted as a 
reduction in colony forming units resulting in an increased lag phase before detection of 
exponential gowth as captured by onset time. Previous studies with other target bacteria 
indicated that OSCN reacted with targets on the bacterial surface through oxidation of essential 
sulfhydryls. This inhibition was to a point reversible if the modified targets could be reduced to 
restore function. To acquire more insight into the nature of the inhibition of the LPO system on P. 
aeruginosa, the treated bacterial suspensions were sampled during the treatment period and 
plated to TSA to determine the number and nature of the actual recoverable colony forming units 
of P. aeruginosa kinetically. 
Two groups of treatments, LPO/SCN/H2O2 and H2O2 alone, were selected and non-
treated bacteria suspensions were used as control groups.  The P. aeruginosa suspension with a 
concentration of 106 CFU/mL were cultured and divided into three groups. At the time points of 
0, 2, 4 and 6 hours, aliquots from each treatment group were spiral plated onto tryptic soy agar 
(TSA). After overnight growth at 37oC in ambient atmosphere, colonies were examined for their 
appearance and the quantitation of recoverable CFU/ml. The appearance and colony numbers of 
the sample treated by LPO/SCN/H2O2 and H2O2 were compared with that of the control group 
such that the bacterial killing and any influence on colony growth could be determined. 
Moreover, two different H2O2 concentrations in LPO/SCN/H2O2 system were tested. In the 
previous experiments that measured bacterial growth kinetics, the bacteria remained exposed to 
the antimicrobial agents throughout the analyses. In contrast, in these experiments the treatment 
mixture was sampled through the progression of early incubation and plated to the surface of 
media that did not contain antimicrobial agents. This transfer to fresh media effectively dilutes 
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the antimicrobial agents. Further dilution is also accomplished by the diminishing volume of the 
test reaction created by the spiral plating technique. In effect this approach stops the action of the 
agent to determine its effect on the bacterial population at the point of plating. 
As shown in Figure 7(A), the sample containing only 3.44mM H2O2 showed no 
significant inhibition of bacteria growth. When the concentration of H2O2 is increased to 
6.88mM, a one-log reduction in recoverable CFU was observed. On the other hand, the sample 
containing 10 U/mL of LPO, 2mM of SCN and 3.44mM H2O2 resulted in a two-log reduction. If 
the concentration of H2O2 is increased to 6.88mM with the same dosages of LPO and SCN, 
bacteria growth is entirely inhibited.  
With the higher concentration of H2O2 (6.88mM), pictures taken from representative 
plates in different time point are provided in figure 7C. After two hours treatment with 6.88mM 
of H2O2, 10U/ml of LPO and 2 mM of SCN, the colonies showed a smaller size than colonies in 
the control group. The quantified results shown in figure 7B, where the number of bacteria with 
LPO/SCN/H2O2 group indicated a three-log reduction compared to controls.  On the contrary, 
with 6.88mM H2O2 treatment there were no differences in colony size or number observed. After 
four hours of treatment with LPO/H2O2/SCN, very few colonies were recoverable. Moreover, no 
colonies were recovered after 6 hour in this group, suggesting that complete killing by 
LPO/SCN/ H2O2 occurs around the fourth hour. Meanwhile, at the time points of 2, 4, and 6 
hours, both number and size of colonies treated with H2O2 in the absence of LPO did not exhibit 
significant difference compared to the control.  
As shown in Fig. 7C, at the lower concentration of H2O2 (3.44 mM), H2O2 in the absence 
of LPO did also not present any discernible effect on the bacteria, for both colony characteristics 
and number. However, as shown in Fig. 7F, if the bacteria were treated with an equivalent 
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concentration of H2O2 in the presence of LPO and SCN for 2 hours, both small and normal size 
colonies were recovered on the plate. (Fig. 7F). Regarding the effect on the number of bacteria, 
the quantified results are provided in Fig. 7E. While the small colonies were recoverable at 106 
CFU/mL, the normal size colonies were present at 105 CFU/mL at the two hour time point. Here 
the number of total recoverable CFU despite their small size are not significantly reduced 
compared to that of the control.  After 4 hours of treatment, however small colonies cannot be 
found on the plate, but the normal size colonies are still recoverable at105 CFU/mL. After six 
hours, the number of normal size colonies increased more than ten-fold compared with that 
recovered at four hours. There were no small colonies in evidence.  
Based on the observations in this set of experiments, we deduce that the small colonies 
observed in the group with LPO/SCN/H2O2 treatment are due to a delay in the initiation of 
bacterial growth. Based on the understanding of OSCN mechanism of inhibition, the treatment 
may interrupt the metabolism of bacterial cell, which could further inhibit the growth of bacteria. 
However, when the bacteria are exposed to OSCN alone for 2 hours, the inhibition is reversible 
as the cells are capable of recoverable colonies. In clinic, the small-colony variant of P. 
aeruginosa has also been observed in respiratory tract specimens from patients with CF. (34) 
Later, it has been identified that pel and psl gene clusters and elevated intracellular cyclic di-
GMP (c-di-GMP) levels contribute to small-colony morphotype of P. aeruginosa. (35) To verify 
whether small colonies in the treatment of LPO/SCN/H2O2 is also due to inducing gene mutation, 
small colonies were transferred onto another TSA plate. After overnight culture, all small 
coloines were recovered as normal size (data not show), suggesting that the small colonies 
observed with treatment by the  LPO/SCN/H2O2 system are not via inducing gene mutation.  
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After four hours of inhibition of metabolism, the bacteria may die (failed to recover) as a 
result of starvation. On the other hand, the observations of normal and small colonies with the 
LPO system with lower concentration of H2O2 suggest partial inhibition from the LPO system 
suggesting insufficient OSCN is generated to target all the bacterial cells. While bacterial cells 
are attacked by OSCN and eventually die after 4 hour of treatment, a portion of the bacteria 
escape the antimicrobial effect of OSCN and are capable of normal growth.  
Blocking by Catalase or GSH of the inhibitory effects of LPO/SCN/H2O2 system.  
Glutathione (GSH) is another important antioxidant in ELF in lungs besides SCN. The 
transportation into extracellular of GSH has been shown to directly involve CFTR, and 
pronounced depletion in ELF of lung has been observed in CF patients.  In the normally healthy 
airway, GSH is present in high concentrations in the epithelial lining fluid. Together with other 
ions in ELF on the surface of epithelial cell, it is presumed to play an important role in host 
immune defense in the lung. Due to its antioxidant role, that can reduce amount of oxidant like 
H2O2, we were interested in its influence on the effect of LPO/SCN/H2O2 on CF pathogens.   
In this set of experiments, two combinations of LPO/SCN/H2O2 were selected. One group 
with 6.88mM H2O2 results in total inhibition of PAO1 growth in TSB and the other combination 
with 3.44mM H2O2 resulted in partial inhibition of PAO1growth. To this combination, either 
GSH to 128mM or catalase to 100U/mL were added at different times during bacterial treatment 
to include immediately following addition of the target bacteria or after one or 2 hours of 
treatment.  As shown in Fig. 8, with the higher concentrations of H2O2 in the LPO system, 
initially adding GSH could rescue 10% of the recoverable CFU. At this time point, adding 
catalase fully rescued the bacteria from inhibition by the LPO system. However, if either the 
GSH or catalase were added following one hour of treatment, less than 102 CFU/ml bacteria 
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were recovered; after 2 hours, no rescue could be demonstrated. Similar phenomena were 
observed in LPO/SCN/H2O2 with 3.44 mM H2O2. That substantial blocking can be observed if 
adding GSH or catalase immediately with LPO/SCN/H2O2, and the effect decreased significantly 
suggests that the rescue of GSH is possibly from overwhelming H2O2 and prevent the reaction of 
LPO/SCN/H2O2 system, instead of clearing the product OSCN or reversing its effect in this 
system. It would seem important in future studies to examine intermediate time intervals between 
initial and one hour for the blocking/rescue effects of GSH and catalase. 
Influence of SCN on hypochlorite-killing on P. aeruginosa.   
Besides playing a role in the LPO/SCN/H2O2 system to inhibit pathogens in the host, 
another important property of SCN that contributes to host protection is to reduce the amount of 
HClO in human body through antioxidant potential. This property is particularly valuable for the 
treatment of CF lung disease, considering lung damage is purportedly mainly caused by the 
exaggerated inflammatory response, and that HClO is likely one of the main tissue-noxious 
molecules generated in this response. Studies have shown that by adding extra SCN, more host 
cell can be protected from HOCl damage since SCN non-enzymatically reduces HClO and 
converting it to tissue-innocuous molecules (i.e. OSCN and Cl).  
However, a question remained in the previous studies, i.e. whether adding SCN could 
also decrease the antibacterial effect of HClO such that the innate immune defenses in the airway 
are compromised. To address this question, we compared the inhibitory effect of HClO with and 
without adding SCN. Specifically, in one group, only HClO was added to coincubate with the 
samples containing P. aeruginosa with an initial density of 106 CFU/mL. As shown in Figure 3A, 
when the concentration of HClO exceed 9.75 mM, the growth of PAO1 is completely inhibited; 
three logs of inhibition can be observed when the concentration of HClO reached 4.875mM.  
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Next, titrated concentrations of SCN were added into bacteria culture media containing 
HClO. As shown in Fig. 3A, substantial protection can be observed for the goups with the HClO 
concentrations are 9.75mM and 4.875 mM. In both groups, adding 2.5mM SCN resulted in the 
best protection for PAO1 to resist HClO killing. As shown in Fig. 3B, with 9.75mM HClO in the 
sample, which resulted in complete inhibition of P. aeruginosa, 2.5mM SCN rescued more than 
104 CFU/mL bacteria. An interesting observation is that, when the SCN concentration was 
increased, the effect of protection on bacteria growth tended to decrease. In the 9.75mM HClO 
group, adding 20mM and 10mM SCN, only 103 CFU/mL bacteria were rescued. The same 
tendency occurred in 4.875mM HClO group, which only provide partial inhibition on P. 
aeruginosa.  The highest level of protection occurred during the co-incubation with 2.5mM SCN, 
where approximately 106 CFU/ml bacteria were detected. On the contrary, only 103 CFU/ml 
bacteria were detected at 4.875 mM HClO. However, with 20mM SCN adding to 4.875 mM, the 
bacteria number is 10 fold less than that for 2.5mM SCN. 
These results suggest that not only does SCN protect host cell from the killing due to 
HClO, but SCN is also able to rescue pathogens from HClO killing. However, the protection 
decreases when amount of SCN increases to a certain level, presumably due to the extra OSCN 
generated from oxidized SCN that can inhibit bacteria growth.   
 
Susceptibility of mucoid strain of P. aeruginosa to oxidant stress.   
A unique character of CF lung infection is that P. aeruginosa is the dominate pathogen in 
more than 80% of the patients, while most of other immune compromised diseases are often 
infected by various pathogens. Although the exact reason for P. aeruginosa to dominate in CF 
lung is under debated, several studies have shown that this pathogen undergoes several genetic 
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transformation along with the progress of CF lung infection, and it is generally accepted that the 
genetic flexibility of P. aeruginosa plays an important role in its ability to dominate in the CF 
airway.  Among different genetic change, the conversion to mucoidy of P. aeruginosa is 
considered as the most characteristic and important adaptation.  
Current speculation regarding the purpose for conversion of P. aeruginosa to over-
production of alginate to form mucoidy strains is to protect against stress from inflammation in 
the CF lung, like reactive oxygen species, oxidant molecule; however, there have been no studies 
demonstarting an association between alginate production and ROS resistance. Thus, we applied 
our method of measurement of inhibition of bacteria growth to compare the susceptibility of 
mucoid and non-mucoid strain to H2O2, Hclo, and LPO/SCN/ H2O2 system. Three strains were 
chose in this comparison. One mucoid strain PaM is a laboratory-derivedmutant of PAO1, the 
other mucoid strain C3873 is a clinical sputum isolate from a CF patient.  
Initially, the correlations between onset time to exponential growth vs. initial inoculum size were 
established for both mucoidy strains as had been done for PAO1. The influence of log10 titration 
starting inoculum on growth curves are shown in Figure 10 A and B As with PAO1, the 
influence of starting inoculum density on time to onset of exponential growth of both mucoidy 
strains werehighly linear with correlation coefficients of 0.9986 and 0.9997 respectively.  
Next, the three strains of P.aeruginosa were exposed to four different treatments: H2O2 
alone, H2O2 with LPO and SCN, HClO alone, and HClO with SCN. First of all, as showed in 
Figure 9A the results showed that PAO1 was not totally inhibited until the concentration of  
H2O2 reached 64mM; however, there was total inhibition of the two mucoidy with H2O2 
concentrations as low as 4 mM. These results indicated that the non-mucoidy strain of P. 
aeruginosa was actually more resistant to H2O2, suggestiong that the over-production of alginate 
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does not serve to protect against reactive oxygen species.  Moreover, PAO1 proved more 
resistant to the LPO system than the two mucoid strains. While LPO system with only 2mM 
H2O2 resulted in total inhibition of PAM and C3837, 8mM H2O2 was required in the LPO system 
for the inhibition of PAO1. (Fig. 9B) This observation also suggested that, in contrast to what 
was observed with PAO1, the LPO/SCN/ H2O2 system did not enhance the inhibition of the 
mucoidy strains compare to H2O2 alone. 
When treated with HOCl, total inhibition of all three strains was observed when HOCl 
was increased to 8mM, which suggested that both mucoidty and non-mucoidy strains of P. 
aeruginosa showed similar susceptibility profiles to this ROS.  We also tested the influence of 
SCN on HClO killing. After 20 mM of SCN addition to titrated concentrations of HClO, the 
protection from SCN in all three strains was observed and there were no significant differences 
in susceptibility between the mucoid and non-mucoid strains  
Effect of LPO/SCN/ H2O2 on mucoidy forming of P. aeruginosa 
It is known that conversion of P. aeruginosa from non-mucoid to mucoid phenotype is 
attributable tooverproduction of alginate. The alginate biosynthetic pathway requires guanosine 
diphosphate-mannuronic acid. Since it is speculated that LPO/SCN/ H2O2 may inhibit bacteria 
growth by interruption of carbohydrate metabolism, it was the purpose of these studies to 
determine if LPO/SCN/ H2O2 influenced the producing of alginate by mucoidy isolates of P. 
aeruginosa.  
In this experiment, we performed spiral plate assay to understand the effect of LPO/SCN/ 
H2O2 system on the two mucoidy strains. Similarly, small colonies are observed after two hours 
of treatment of LPO/SCN/ H2O2, (Fig. 10 & 11). The small colonies can also grow bigger with 
mucoid phenotype later, indicating that the alginate generation was not suppressed by the LPO 
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system. Moreover, colonies did not showed up on plates after 4 hours of treatment of LPO/SCN/ 
H2O2, suggesting that the mucoidy phenotype did not influence the anti-microbial kinetic curves 
of LPO/SCN/ H2O2. Therefore, we further proved that conversion to mucoidy did not protect P. 
aeruginosa from inhibition of the LPO system.  
 Comparisons of susceptibilities of mucoidy vs. non-mucoidy strains of P. aeruginosa by 
disc diffusion assay.  
Besides mucoid conversion on P. aeruginosa, studies also showed that biofilm formation 
is another important characteristic in later stage of CF lung infection. It is evident that mucoidy P. 
aeruginosa colonize in the CF airway as a biofilm rather than in planktonic form and that the 
alginate contributes to the biofilm structure. Therefore, we also investigated whether mucoidy 
strains cultured on a fixed agar surface emulating a biofilm would have demonstrably different 
susceptibilities to antimicrobial molecules like H2O2 and HClO compared to that of planktonic 
targets.  
In this experiment, we applied the disc diffusion assay to mimic the biofilm condition of 
P. aeruginosa. Varying concentrations of H2O2 and HClO were titrated to blank filter paper disks 
placed on TSA plates inoculated with the three different strains of P.aeruginosa. After overnight 
culture, the sizes of the zones of inhibition were measured as a diameter to estimate susceptibility 
of each strain. Specificly, two cultural conditions were applied to the clinical strain, C3873. 
Based on our previous studies, aerobic chamber with 5% CO2 resulted in exaggerated production 
of alginate on C3873; whereas, growth using nitrate respiration in an anaerobic atmosphere 
containing 5% CO2 suppressed alginate production. Here we utilized aerobic growth on TSA 
plates containing 1% NO3, which our preliminary data determined suppresses the alginate 
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production from the clinical mucoidy strain. These two cultural circumstances allowed 
comparisons of the susceptibilities of the target strains grown under the two conditions.  
 
In Fig. 12A and B, we observed smaller zones of inhibition by H2O2 with PAO1 
compared to that with the two mucoidy strains consistant with the planktonic data suggesting that 
PAO1 is more resistant to H2O2 inhibition. Furthermore, there was no evidence that either 
increased (5% CO2) or decreased (1% NO3) alginate production altered susceptibility to either 
HClO or H2O2 under conditions that mimic biofilm conditions.(Fig. 12C and D)  
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Discussion 
In the normally healthy human body, there are two general mechanisms that can be 
utilized to eliminate the inhaled bacteria in airway (36):  the mucociliary escalator physically 
removes inhaled particles, and the soluble antimicrobial proteins of the secretions that bathe the 
airway surfaces such as secretory antibodies or innate defense proteins including defensin, 
lysozyme, lactoferrin and lactoperoxidase that exert both bacteriostatic or bactericidal effects. 
When considering the relationships between CFTR deficiency/dysfunction and susceptibilities to 
lung infection, hypotheses involving both airway defense mechanisms have been suggested.  
The “dehydration hypothesis” (37) proposes that the loss of normal ionic transport to 
airway surface attributable to CFTR mutation results in insufficient amounts of salt and fluid 
leads to dehydration of the airway surface liquid and a thickening of the surface mucus layer. 
This abnormal, thick mucus contains higher concentrations of mucins and can collapse onto the 
epithelium, thus the cilia on the surface of epithelium fail to work properly to eliminate the 
pathogenic challenges. The failure of ciliary clearance is considered as the first step of CF lung 
infection. Up to now, most of the data supporting this theory is based on air interface human 
bronchial epithelial cell culture system. Studies on this system showed that when small volume 
of liquid is added to normal airway culture, the epithelium is able to maintain an ASL height 
volume of 7m. In contrast, CF airway epithelial culture surface absorbed the liquid rapidly and 
fail to maintain this height  (3m) and the liquid trapped by cilia that have collapsed onto airway 
surfaces.(8)  
A limitation of this theory is that only well-differentiated ciliated epithelial cell cultures 
were examined in studies. In the human body, the airway system also includes submucosal 
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glands, which are the primary source of the exocrine secretions that bathe the airway surfaces. 
These glands consist of both proximal mucous and distal serous epithelial acini and play an 
important role in secreting and transport of ions. (38)  In the mouse model of cystic fibrosis lung, 
normal ASL homeostasis and mucus clearance have been observed.(39) Another limitation of the 
“dehydration hypothesis” is that it failed to explain the unique pathogenic profile of CF lung 
infection. It is widely accepted that CF lung infection has different microbial species compare to 
other lung infection. Moreover, one single pathogen, P. aeruginosa, predominates in the late 
stages of CF lung disease. However, the dehydration hypothesis considers the major defense 
mechanism that protect airway as the mechanical clearance by mucus clearance system, which is 
not bacteria specific. (1) This means all species would be expected to be able to take some 
advantage of the failure of mucus clearance to colonize in CF lung.  Therefore, the role of ASL 
and mucus clearance in CF airway is still under discussion.  
On the other hand, the other hypothesis, normally named “high salt hypothesis”, 
suggested that in the normally healthy airway, the CFTR is responsible for maintaining relatively 
lower level of NaCl solutions on airway surface. The mutated CFTR leads to high salt 
environment on the airway surface, like in sweat duct, which diminish the efficient activity of 
secreted polyionic antimicrobial substances on airway surface. (40, 41). This theory emphasizes 
the role of innate immune proteins by the submucosal glands in keeping airway sterile. It is also 
believed that serous cells require CFTR for secretion of the antimicrobial-rich fluid elaborated by 
submucosal glands in response to pathogens. (42) Therefore, in CF airway, deficient secretion of 
antimicrobial molecules from submucosal glands is followed by infection and inflammation.  
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The central hypothesis of our project is that the ionic composition of the secretions on the 
airway surface is critical to the maintenance of homeostasis in a healthy airway.  The deficient 
CFTR in CF patients results in improper concentrations of selected ions necessary to the function 
of critical soluble innate defense factors. CF lung infection is characterized by a dominating 
pathogen, P. aeruginosa, which is highly associated with disease progress, and mainly drive to 
determine the morbidity, clinical deterioration and mortality. (43) This is very different from 
most genetically determined diseases, since normally large variety of pathogenic species could 
be found in immune compromise subjects. It is also known that P aeruginosa is highly 
genetically flexible and able to actively adapt to the inflammatory, stressful environment in CF 
lung. (32) Therefore, instead of attributing the CF lung disease to dysfunctional mucus clearance, 
we speculate that the abnormal ionic composition of secretion in CF airway caused by deficient 
CFTR creates a unique environment that P. aeruginosa can take advantage of.  
Secretions of submucosal glands in the airway contain soluble antimicrobial components, 
and they play an important role in host immune system. Lactoferrin (6), lactoperoxidase (LPO), 
lysozyme (44), mucins and secretory IgA (S-IgA) are among the principal antimicrobial proteins 
found in exocrine secretions that bathe mucosal surfaces including the conducting airways and 
the oral cavity. The antimicrobial function of those proteins are depended on or regulated by 
different molecules and anions that delivered by glandular ductal epithelial cells or by the 
ciliated epithelium lining the airways. For example, the amount of bicarbonate (HCO3
-) can 
influence the ability of LF of eliminating bacterial by determining the ironing binding site (10); 
also,  the most common reactive oxygen species, hydrogen peroxide, is synthesized by the 
NADPH oxidase family member dual oxidase 2 (DUOX 2) expressed by ductal epithelial cells. 
(45). Besides, anions like GSH and SCN are important antioxidant in airway that can diminish 
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the host cell damage from inflammatory response. (46). Although recognized as a Cl channel 
initially, increasingly studies have shown evidence that all those molecule above are transported 
or regulated by CFTR (47) Therefore, further studies are needed for understanding the link 
between CF lung infection and abnormal molecules in secretions caused by CFTR mutations.  
In my thesis project, we focused on one of the anions, SCN, which have been shown 
decreased in amount in CF airway due to the CFTR mutation.  We investigated its potential 
influence on the clearance of P. aeruginosa in the healthy airway, and how CFTR dysfunction 
contributes to the infection progression of P. aeruginosa in the CF airway, including its influence 
on the the conversion of of this pathogen to the mucoidy phenotype characteristic of the CF 
pathogen.  
SCN has been proposed to play important roles in human host defense systems from two 
different perspectives. (15)  First, SCN is the preferred substrate for peroxidase catalyzed 
reaction with H2O2 to produce HOSCN, a potent antimicrobial agent. The other role of SCN in 
host protection as an antioxidant. It provides the protection on host cell in the inflammatory 
environment via reducing the accumulation of tissue –damaging species from inflammatory 
response, such as H2O2 and OCl
-, and generate tissue innocuous OSCN. (14) 
In the first part of my project, we proved the antimicrobial effect of LPO/SCN/ H2O2 
system. By showing that SCN itself did not influence the growth of P. aeruginosa, and the 
combination of either H2O2 plus SCN or H2O2 plus LPO did not influence the inhibitory effects 
from H2O2 on P. aeruginosa, we showed total inhibition can be observed when three components 
together with 8 fold lower concentration of H2O2. In the next step, we showed the inhibition 
efficiency is dose-dependent on both H2O2 and LPO. These results suggested that with LPO, 
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SCN, and H2O2 all together can generate new component to inhibit the growth of P. aeruginosa, 
rather than just enhance the effect of inhibition from H2O2. 
Lactoperoxidase is a peroxidase that was first identified in cow’s milk. The activity of 
LPO/SCN/H2O2 system has since been identified in sheep airway (24) and the deficiency in SCN 
associated with CFTR dysfunction has been suggested as compromising the antimicrobial and 
anti-inflammatory functions of the LPO system in the CF airway. Studies also showed that all 
three components are concentrated enough to give active antimicrobial effect. The DUOX 
system of ductal epithelial cells has been shown to be a source of H2O2 in the secretions of 
airway surfaces. Although H2O2 itself can damage bacterial cells directly, the levels of H2O2 
encountered in airway are likely too limited (10-6M) for this function to be effective.(48)  
Moreover, our data showed that antibacterial effects of H2O2 are largely influenced by target 
numbers of P. aeruginosa,  due to catalase on the bacterial membrane. Thus, it is suggested that 
LPO/SCN/ H2O2 work together against the P. aeruginosa. Moreover, our experiments 
demonstrated that the antimicrobial effects of OSCN is not influenced by the density of P. 
aeruginosa.  
In addition to the antimicrobial effect of LPO/SCN/H2O2 system, we also studied the 
mechanism of inhibition of this system on P. aeruginosa. It has been found that OSCN 
suppresses the growth of oral pathogens by oxidation of essential thiol groups on glycolytic 
enzymes, disrupting the critical  metabolic process of glycolysis. (49) Another interesting finding 
is that inhibition by OSCN is reversible as some bacteria are capable of regenerating their thiol 
groups after removing the residual oxidant either by exogenous reducing agents or through 
bacterial generation of reducing equivalents. (19) Therefore, the antimicrobial effects of OSCN 
in this situation would be considered as bacteriostatic. However, the characteristic of effect of 
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LPO/SCN/ H2O2 system on the CF pathogen, P. aeruginosa, has never been well studied, though 
several papers described the LPO/SCN/ H2O2 system as having bactericidal activity in the airway. 
(50) 
Based on our experiment, the P. aeruginosa when plated to agar surface after two hours 
treatment with LPO/SCN/ H2O2 yielded small colonies after overnight growth compared to 
controls. These colonies eventually grew to full size and were recovered to normal growth rate 
after transferring to a new plate. This suggested that the inhibition by OSCN of P. aeruginosa 
was also due at least initially (before two hours of treatment) to bacteriostasis, rather than 
causing any irreversible damage to the cell. Furthermore, the small colonies but not the normal 
size colonies disappeared by four hours of LPO/SCN/ H2O2 treatment, suggesting that P. 
aeruginosa starved after interruption of metabolism. Another possibility is that the LPO system 
caused cell damage on P. aeruginosa, but bacterial cells are able to repair some of the damaged 
cells within only two hours, while the damage becomes irreversible after four hours.  
It is also important to note that OSCN may not be the only product from LPO/SCN/ H2O2 
system. It has been speculated that when H2O2 /SCN ratio are high enough, the OSCN can be 
further oxidized to O2SCN and O3SCN. (51) It has been suggested that O2SCN and O3SCN can 
produce irreversible damage to bacterial cells. In our experiment, there is certainly the possibility 
that O2SCN and O3SCN may contribute to the lethal effect of the LPO system on P. aeruginosa.  
Although there is good evidence that OSCN is capable of inhibiting bacterial metabolism 
through oxidation of essential sulfhydryls of target enzymes, there is another aspect worth 
considering. It has been suggested that SCN is associated with large, positive entropies, and is 
considered a chaotropic ions. Chaotropic ions are defined as favoring the transfer of apolar 
groups to water. Moreover, studies have suggested that such chaoptropes can weaken the 
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hydrophobic bonds of membranes and multi-component enzymes and increase the water 
solubility of particulate proteins.(52) Based on this theory, the antimicrobial effect of OSCN may 
also come from the chaotropic prosperity which leads to damage of the bacterial member. In 
theory the single negative charge spread over the increased molecular diameter of OSCN vs. 
SCN would result in more potent chaotropic activities for the oxidized species of SCN. 
In my thesis, we also looked at the antioxidant role of SCN. In most studies, SCN is 
proposed as a host beneficial molecule in CF lung inflammation, due to its capability of limiting 
accumulation of harmful inflammatory factors including HClO and H2O2. As the neutrophil is 
major inflammatory cell recruited to the CF airway surface, large amount of HClO are generated 
by MPO/Cl/ H2O2 resulting from the activation of neutrophils, which is responsible for host cell 
injury and contributes to failure of respiration in CF patients. (53). Xu Yanping et. al have 
showed that adding SCN protects the lung epithelial cell lining against injuries caused by MPO 
activity, and also proved the protection is due to SCN inhibited OCl production by MPO. (14) 
However, the fact should not be ignore is that the main purpose of neutrophils to generate 
HClO is to kill invading pathogens in our body. Therefore, one question arises when considering 
SCN as a potential therapeutic for reducing HClO from MPO system in order to limit host 
damage: whether adding SCN also protects the pathogen from the MPO system thus providing 
the window of opportunity to infect the CF lung. From our experiments, we showed that with 
2.5mM SCN, P. aeruginosa is almost fully rescued from total inhibition with 9.75mM HClO. 
Interestingly, the number of bacterial cells rescued from SCN was decreased when SCN 
concentration went higher. Our explanation towards this phenomenon is that that when SCN 
reacts with HClO, the antimicrobial species OSCN is generated. When SCN increased to 
sufficient concentration the OSCN levels were adequate to achieve inhibition of growth of P. 
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aeruginosa. In situ it would be expected that the HClO would not be the only source for OSCN 
would also be generated by the peroxidase dependent oxidation by H2O2. 
Therefore it seems that SCN can reduce the concentration of cytotoxic HClO to generate 
a more microbe specific, tissue-innocuous species, OSCN, serving the dual function of 
antimicrobial and antiinflammatory. While the antimicrobial activity of OSCN would be 
interpreted as being greater than of H2O2, it is evident that this activity is less potent than that of 
HClO. Thus, we believe that caution should be exercised when considering adding SCN as a 
therapeutic molecule to CF patient.  
Another important concept in our hypothesis is that the exocrine secretions of the airway 
submucosal glands serve to deliver critical innate defenses to the healthy airway surface. These 
defense mechanisms are attributable not to one molecule but to a combination of interdependent 
factors that are dependent on a variety of ions for maintenance of a heathy homeostasis to limit 
potential pathogens from establishing an infection in the airway.  
Although several studies have suggested that SCN may be beneficial in the airway, both 
in antimicrobial and antioxidant roles, none of the studies consider the possibility that the effects 
of SCN might be influence by other molecules in the airway surface liquid. However, it should 
be noted that SCN does not exist alone in the airway, but coexists with all the other molecules in 
ASL (36). Thus, in order to investigate the role of SCN in airway immune system, it is important 
to understand the interactions of SCN with other molecules in the secretions of submucosal 
glands and how they are modified by the ciliated epithelial surfaces that they bathe.  
It is hard to define the interaction between SCN and all the other molecules present in on the 
airway surfaces. Therefore, in my thesis project, we began to look at GSH, an important 
tripeptide that is also delivered to the airway surface liquid. Normally, GSH is synthesized and 
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functions inside human cells and serve as antioxidant that can prevent damage caused by reactive 
oxygen species such as free radicals and H2O2. However, on the airway GSH is secreted through 
the apical surface of the cell to the airway surface liquid by a CFTR dependent mechanism. 
(11)It is suggested that the function of GSH in airway is also limiting accumulation of reactive 
oxygen species. (54) Consistent with the role of CFTR in glutathione transport, the amount of 
GSH is also diminished in the CF airway due presumably to absence or dysfunction of CFTR.  
As discussed before, SCN is considered as an antimicrobial molecule, because it is able 
to be oxidized by LPO with H2O2to generate OSCN, which is able to inhibit growth of bacteria. 
However, when GSH and SCN exist together in the secretion, it is possible that GSH limits the 
generation of OSCN owing to its ability to consume H2O2 as a substrate for GSH-peroxidase(12). 
Another possibility is that GSH can directly reduce amount of OSCN due to its antioxidant 
potential to prevent antimicrobial function of the LPO system either by blocking its activity or 
direct reaction with OSCN.  
Based on our results, it is clear that when LPO, SCN, H2O2and GSH are present together, 
the initial antimicrobial activities of the LPO system on P. aeruginosa can be dampened. 
However, if LPO/SCN/ H2O2system is allowed to react with the bacterial target for a period of 
time before the addition of GSH, the antimicrobial effects cannot be reversed. Therefore, these 
studies imply that the GSH can decrease the antimicrobial function of LPO/SCN/ H2O2system 
only by blocking the enzymatic activity, but not by reversing the OSCN oxidized sulfhydryls. 
Considering the high concentrations of GSH in epithelial lining fluid in the health airway, it is 
important to consider its influence on any potential antimicrobial functions of SCN in normally 
healthy airways.  
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The last part in this thesis project, investigated the antimicrobial activities of SCN against 
CF characteristic mucoidy strains of  P. aeruginosa .  As discussed before, chronic infection of 
the cystic fibrosis lung by P. aeruginosa is the major cause of morbidity and mortality among CF 
patients. (27)  Due to the high selective pressure of inflamed CF airway, from the initial 
colonization to establish a chronic infection, P. aeruginosa undergoes significant genetic 
changes to adapt to this environment. It has been shown that, at the younger ages of CF patients, 
the majority of P. aeruginosa strains infecting are acquired from the environment and undergo 
characteristic adaptations in the progession to the late stages of CF infection, such as excessive 
production of extracellular alginate, loss of the ability to produce LPS O-side chains, loss the 
color of colony, loss of motility and modifications in quorum sensing molecules. (32) 
Among those changes, one of the most prominent virulence determinants in the chronic 
CF airway disease is the conversion to the mucoidy phenotype characterized by alginate 
production. Clinical studies showed that the most profound lung function deline occurs when P. 
aeruginosa transitions to this mucoidy phenotype, and this change can be observed in more than 
80% of late stage CF lung infections. (31) It is believed that the mucoidy characteristic aids the 
persistence of P.aeruginosa in the CF lung, and it has been considered the hallmark of chronic 
progression of infection in the CF lung.  
The environment of the CF lung presents an escalating variety of stressors, including high 
concentrations of reactive oxygen and nitrogen species, associated oxygen limitations, nutrient 
limitations and locally and systemically delivered antibiotics. It is believed that alginate 
production is a strategy for P. aeruginosa creates an extracellular biosphere environment that 
provides a barrier to such stressors. Indeed, studies have showed that by consistently treated with 
low levels of H2O2, or cultured in anaerobic growth conditions, P. aeruginosa can be induced 
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from the smooth, non-mucoid wild type to the mucoidy phenotype. (29, 33) However, we did not 
find any studies that indicated that excessive alginate production would afford protection of this 
pathogen against H2O2or other reactive oxygen species. There is data that indicate that the 
transition to the mucoidy phenotype is associated with upregulation of genes such as catalase, 
superoxide dismutase and flavoheme protein that would be assumed to afford protection from the 
activities of ROS and RNS.(33) 
In our studies, by comparing the titrations of reactive oxygen species HClO and H2O2 
give totally inhibition on mucoid vs. non-mucoid strains of P. aeruginosa, we did not observed 
increased resistance of the alginate producing strains to the antimicrobial effects of either HClO 
or H2O2., which suggested that mucoidy did not afford protection of P.aeruginosa. In contrast, 
we observed that wild type P.aeruginosa required higher concentrations of H2O2 to get total 
inhibition than the other two tested mucoidy strains. Therefore, from our studies, we did not see 
mucoidy function as protection for P. aeruginosa against inhibition from reactive oxygen species. 
Still, there are other potential advantages of mucoidy formation that need to be considered. It is 
suggested that alginate promotes the biofilm formation of P. aeruginosa and helps the pathogen 
establish integration into the thick mucus layer characteristic of the CF airway. (55) Further, 
alginate keeps phagocytes from entering the biofilms and gaining the direct access likely 
required for bacterial killing by these innate defense cells.(56) .  
Another observation in our study was that due to the higher sensitivity of the mucoidy 
strains of P. aeruginosa, the LPO system did not show significantly higher inhibitory effects 
when compared to that with treatment with H2O2 alone. Therefore, it is possible that LPO/SCN/ 
H2O2may play an important role in clearing the initial environmentally challenged P. aeruginosa 
that protects the normally healthy airway in contrast to the failure in the compromised CF lung. 
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In the CF lung there would be no SCN to convert ineffective concentrations of H2O2 to the more 
effective OSCN species necessary to resolve the challenge with the H2O2 resistant environmental 
P. aeruginosa.  Consider the alginate are form the main structure of P. aeruginosa biofilm, and 
mucoidy strains often exist in biofilm structures, we also utilized a disk diffusion assay on an 
agar surface to mimic the surface growth of the biofilm structure. These approaches failed to 
reveal any protection against either H2O2 or HClO that could be attributed to alginate production 
even under exaggerated alginate production induced by a 5% CO2 atmosphere compared to the 
alginate suppressive conditions of 1% NO3 observed with the clinical isolate C3873.  
In summary, our current data confirmed the antimicrobial potential of SCN against P. 
aeruginosa in the airway. On the one hand, it is clear that the presence of LPO and SCN at 
optimal concentrations can significantly enhance the antimicrobial activity of H2O2 against 
relevant environmental isolates of P. aeruginosa through generation of OSCN. Thiocyanate is 
also capable of reducing the less discriminating but apparently more potent anti-P. aeruginosa 
activity of HClO. The chemistry of this interaction should result in conversion of the HClO to 
HOSCN and NaCl that should reduce the oxidative damage to the host while generating the 
microbe specific antimicrobial species of OSCN. Presumably this would be an advantage to the 
host as the bacteria are effectively growing in the presence of massive numbers of HClO 
generating neutrophils in the CF airway. Furthermore, there is no evidence that the normally 
healthy airway is dependent on the neutrophil or its HClO product for defense against P. 
aeruginosa challenge. It seems more likely that the soluble content of the exocrine secretions 
that bathe these surfaces provide antimicrobial activity necessary to prevent P. aeruginosa 
colonization and growth. The current studies indicate that LPO and its SCN substrate are capable 
of inhibiting environmental P. aeruginosa at concentrations that may be found in exocrine 
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secretions such that OSCN may make important contributions to the defense against this 
pathogen. By extension, deficiencies in SCN in the CF airway surface liquid may predispose to 
the unique susceptibility to infection with this opportunistic pathogen. 
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FIGURES 
 
Figure 1 Measurement of bacteria density by onset time in growth curve. 
A) 
 
B) 
 
C) 
 
Measurement of bacteria density by onset time in growth curve A) Growth curves of P. 
aeruginosa in broth cultures wtih gradient initial density.  20μL of P. aeruginosa culture media 
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were added into 200 μl TSA media, the starting bacterial density was adjusted to 108 CFU/mL 
using comparison to MacFarland standards serial ten-fold dilutions of this bacterial suspension 
was used. B) The time growth curve takes to enter log phase growth and this time to exponential 
growth can be uniformly captured by determining onset time to an OD610nm of 0.2 (red line). C) 
Linear regression was performed between the starting inoculum size (CFU/ml) and the time to 
achieve this threshold OD value, i.e. the onset time. 
 
Figure 2 SCN did not influence growth of bacteria by itself: 
 
 
SCN did not influence growth of bacteria by itself:  A titration of concentrations (0.75 - 
40mM) of SCN was added to replicate wells of the culture media prior to inoculation with 
PAO1(108CFU /ml) The effect of SCN on microbes were measured by relative bacteria number 
indicated by onset time for each sample.  
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Figure 3  Inhibitory effect of H2O2 on PAO1 is influence by bacteria density. 
A) 
  
B） 
 
Inhibitory effect of H2O2 on PAO1 is influence by bacteria density.     
P. aeruginosa (A) and S. mutans (B) with two different starting inoculum of  107 CFU/ml (blue) 
and 105 CFU /ml (red) of were exposed to a titration of concentrations (0. 10mM to 110mM) of 
H2O2 for overnight culture. Higher density of P. aeruginosa showed higher resistant to H2O2 
killing. Different susceptibility to to H2O2 killing did not been observed in different density of S. 
mutans.  
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Figure 4 The enhanced antimicrobial activity of H2O2 is dependent on both LPO and SCN 
 
 
The enhanced antimicrobial activity of H2O2 is dependent on both LPO and SCN  
107 CFU /ml P. aeruginosa were exposed to A titration of concentrations (0. 10mM to 110mM) 
H2O2 alone (blue), plus only SCN (orange), plus only LPO (yellow) or SCN plus LPO( grey). 
Total inhibition can be observed with 6.88mM H2O2 with LPO plus SCN group compare to H2O2 
alone. No significant difference can be observed with the other two group (H2O2 with SCN, 
H2O2 with LPO) 
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Figure 5 Dose dependence of H2O2 /LPO for growth inhibition of PAO1 
A) 
 
 
 
B)                                                                                 C) 
 
Dose dependence of H2O2 /LPO for growth inhibition of PAO1: 107 CFU/ml P. aeruginosa 
were exposure to four concentrations (from 6.88 to 0.78mM) of H2O2 and ten concentrations 
(from 10 to 0.3125U/ml) of LPO. TSB Plus 2mM SCN media was used to dilute all the reagents. 
A) Growth curves of P. aeruginosa in all the treatment. B) Growth curves with P. aeruginosa 
with same concentration of LPO (5u/ml) and SCN (2mM), and four different concentration of H 
H2O2.  C) Growth curve with P. aeruginosa with same concentrations of H2O2 (3.44mM) and 
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SCN (2mM) and 10 group of LPO. The level of inhibition was dependent on both the activity of 
the LPO and the concentration of H2O2. 
 
 
Figure 6 Antimicrobial effect of LPO/SCN/ H2O2 did not been influence by target density 
 
 
 
B) 
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C) 
 
 
Antimicrobial effect of LPO/SCN/ H2O2 did not been influence by target density two 
inoculum densities of PAO1 (107 CFU/mL and 106 CFU/mL) were treated in the presence of 
2mM SCN in microtiter format with H2O2 in two-fold dilutions added vertically, and the LPO in 
two-fold dilutions added laterally as a checkerboard. No LPO were set up as control group. 
Growth curves (A) of all the samples were acquired. The efficiency of inhibition of were 
estimated as onset time in each group. In 106CFU/mL of P. aeruginosa, 6.88mM and 3.44mM 
H2O2 alone can totally inhibit growth of bacteria.(B). With both 1.72 mM H2O2 and 0.86mM 
H2O2, the same inhibitory activity can be achieved with either of the two target densities of P. 
aeruginosa. (C) 
 
 
 
Figure 7 Investigate of mechanism of antimicrobial effect of LPO/SCN/ H2O2 system on P. 
aeruginosa by spiral plating assay 
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Investigate of mechanism of antimicrobial effect of LPO/SCN/H2O2 system on P. 
aeruginosa by spiral plating assay.  A) Two concentrations (3.44mM and 6.88mM) of H2O2 
were selected in this experiment in order to acquire the mechanism of both total inhibition and 
partial inhibition from LPO/SCN/ H2O2 system. 3.44mM H2O2 (B) and 6.88mM H2O2 applied in 
two groups of treatments, LPO/SCN/H2O2 and H2O2 alone in spiral plating assay. Non-treated 
bacteria suspensions were used as control groups.  The P. aeruginosa suspension with a 
concentration of 106 CFU/mL were cultured and divided into three groups. At the time points of 
0, 2, 4 and 6 hours, aliquots from each treatment group were spiral plated onto tryptic soy agar 
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(TSA). After overnight growth at 37oC in ambient atmosphere, colonies were examined for their 
appearance and the quantitation of recoverable CFU/ml.  
 
 
 
Figure 8 Blocking by Catalase or GSH of the inhibitory effects of LPO/SCN/ H2O2 system.
 
 
Blocking by Catalase or GSH of the inhibitory effects of LPO/SCN/ H2O2 system. . One 
group with 6.88mM H2O2 results in total inhibition of PAO1 growth in TSB and the other 
combination with 3.44mM H2O2 resulted in partial inhibition of PAO1growth. To this 
combination either GSH to 128mM or catalase to 100U/mL were added at different times after 
during bacterial treatment to include immediately following addition of the target bacteria or 
after one or 2 hours of treatment. That substantial blocking can be observed if adding GSH or 
catalase immediately with LPO/SCN/ H2O2.  
 
Figure 9 Influence of SCN on hypochlorite -killing on PAO1. 
  A) 
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B) 
   
 
Influence of SCN on hypochlorite-killing on PAO1.   
Inoculum densities of 106 CFU/mL PAO1 were treated in the presence of 20mM SCN in 
microtiter format with H2O2 in two-fold dilutions added vertically, 128mM HClO and the in two-
fold dilutions added laterally as a checkerboard. The group with only HClO was set as control 
group. When the concentration of HClO exceed 9.75 mM, the growth of PAO1 is completely 
inhibited; three logs of inhibition can be observed when the concentration of HClO reaches 
4.875mM.(A) In both groups, adding 2.5mM SCN resulted in the best protection for PAO1 to 
resist HCLO killing. (B) 
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Figure 10 Susceptibility of mucoid strain of P. aeruginosa to oxidant stress.   
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Susceptibility of mucoid strain of P. aeruginosa to oxidant stress.  The correlation between 
onset time in growth curve and initial density in bacteria sample were also measured in both 
mucoid strain PAM (A) and C3873(B), both strain showed highly linear, and the correlation 
coefficient is 0.9986 and 0.9997. Three strains of P.aeruginosa were exposed to four different 
group of treatment: H2O2 alone(C), H2O2 with LPO and SCN(D),and HClO alone(E).   
 
 
Figure 11 Effect of LPO/SCN/H2O2 system on mucoidy forming of P. aerginosa. 
A） 
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4 hours 
   
B) 
C3837 LPO/SCN/ H2O2 SCN/H2O2 Control 
2 hours 
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Effect of LPO/SCN/ H2O2 system on mucoidy forming of P. aeruginosa.  
 
6.88mM H2O2, 10 U/mL, 2mM SCN were incubated with PaM (A)and C3783 (B) to exam the 
effect of LPO/SCN/ H2O2 system on generation of alginate in mucoid strain of P. aeruginosa. 
H2O2 alone and pure bacteria samples were used as control groups. After 2 and four hours of 
treatment, 5μL culture were took to do spiral plating. The result indicated that small colonies can 
also be found in mucoid strain after 2 hours of LPO/SCN/ H2O2 treatment.  
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Figure 12 Susceptibility of mucoid and unmucoid stratin of P. aeruginosa by disc diffusion 
assay. 
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Susceptibility of mucoid and unmucoid stratin of P. aeruginosa by disc diffusion assay. Disc 
diffusion assay were applied to mimic the biofilm condition of P. aeruginosa. Varies 
concentration of H2O2 (A, B) and HClO (C, D) were added to filter paper disks and placed on 
TSA plates with three different strain of P.aeruginosa. Here we also applied a TSA plate with 1% 
NO3, which can suppress the alginate production from c3837 strain. After overnight culture, the 
size of ring were measured to estimate susceptibility of each strains
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